Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/25/25 16:10 | 3/21/25 | ALNY | Health | Drug | Pharmaceutical Preparations | Garg Pushkal | MA | O | CMO,EVP | 4 | S.dm | -4,500 | 274.94 | 0 | -16 | 25 | D | |||||||||||||||
3/25/25 16:09 | 3/24/25 | ALNY | Health | Drug | Pharmaceutical Preparations | Pyott David E I | MA | D | 1 | S.d | -2,225 | 299.00 | 0 | -7 | 28 | D | ||||||||||||||||
3/5/25 16:22 | 3/3/25 | ALNY | Health | Drug | Pharmaceutical Preparations | Fitzgerald Kevin Joseph | MA | O | CSO,EVP, | 3 | S.dm | -1,321 | 246.66 | 0 | -5 | 14 | D | |||||||||||||||
3/5/25 16:22 | 3/3/25 | ALNY | Health | Drug | Pharmaceutical Preparations | Tanguler Tolga | MA | O | EVP,Chie | 2 | S.d | -239 | 242.69 | 0 | -1 | 28 | D | |||||||||||||||
3/5/25 16:21 | 3/3/25 | ALNY | Health | Drug | Pharmaceutical Preparations | Poulton Jeffrey V. | MA | O | EVP,CFO | 3 | S.d | -747 | 246.87 | 0 | -3 | 48 | D | |||||||||||||||
3/5/25 16:20 | 3/3/25 | ALNY | Health | Drug | Pharmaceutical Preparations | Greenstreet Yvonne | MA | DO | CEO | 3 | S.d | -1,956 | 244.75 | 0 | -8 | 99 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |